Calcium channel blockers may improve treatment for pancreatic cancer patients receiving gemcitabine-based chemotherapy, according to recent findings published in the Proceedings of the National ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

I have found that some patients with depression seem to improve when calcium blockers are discontinued. Are there any data to support this? What would be your preference as a replacement for a calcium ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be ...

Myotonic dystrophy is one of the most common forms of muscular dystrophy. It is a genetic condition that causes progressive muscle weakness and wasting. No treatments currently exist that slow the ...

Calcium channel blockers constitute a class of antihypertensive agents that inhibit voltage-dependent calcium influx in vascular smooth muscle and renal cells. In patients with hypertensive kidney ...

A meta-analysis suggests adverse events are often falsely attributed to BP-lowering drugs, leaving patients undertreated.

Please provide your email address to receive an email when new articles are posted on . CCB users had 39% higher odds of glaucoma on average, as well as thinner inner retinal thickness, vs. non-users.

Please provide your email address to receive an email when new articles are posted on . Beta-blockers more effectively reduce risk for death or hospitalization in people with HFpEF compared with ...